Coordinatore | ST. ANNA KINDERKREBSFORSCHUNG
Organization address
address: ZIMMERMANNPLATZ 10 contact info |
Nazionalità Coordinatore | Austria [AT] |
Sito del progetto | http://www.encca.org/ |
Totale costo | 14˙221˙575 € |
EC contributo | 11˙997˙958 € |
Programma | FP7-HEALTH
Specific Programme "Cooperation": Health |
Code Call | FP7-HEALTH-2010-single-stage |
Funding Scheme | NoE |
Anno di inizio | 2011 |
Periodo (anno-mese-giorno) | 2011-01-01 - 2015-12-31 |
# | ||||
---|---|---|---|---|
1 |
ST. ANNA KINDERKREBSFORSCHUNG
Organization address
address: ZIMMERMANNPLATZ 10 contact info |
AT (WIEN) | coordinator | 1˙643˙402.80 |
2 |
INSTITUT GUSTAVE ROUSSY
Organization address
address: Rue Camille Desmoulins 39 contact info |
FR (VILLEJUIF) | participant | 830˙002.00 |
3 |
UNIVERSITY COLLEGE LONDON
Organization address
address: GOWER STREET contact info |
UK (LONDON) | participant | 739˙313.60 |
4 |
CHRISTIAN-ALBRECHTS-UNIVERSITAET ZU KIEL
Organization address
address: OLSHAUSENSTRASSE 40 contact info |
DE (KIEL) | participant | 695˙664.50 |
5 |
INSTITUT CURIE
Organization address
address: 26, rue d'Ulm contact info |
FR (PARIS) | participant | 638˙373.21 |
6 |
SIOP Europe
Organization address
address: Avenue E.Mounier 83 contact info |
BE (Brussels) | participant | 550˙080.40 |
7 |
Academisch Medisch Centrum bij de Universiteit van Amsterdam
Organization address
address: MEIBERGDREEF 9 contact info |
NL (AMSTERDAM) | participant | 519˙307.00 |
8 |
AIT Austrian Institute of Technology GmbH
Organization address
address: Donau-City-Strasse 1 contact info |
AT (WIEN) | participant | 504˙788.95 |
9 |
UNIVERSITA CATTOLICA DEL SACRO CUORE
Organization address
address: Largo Agostino Gemelli 1 contact info |
IT (MILANO) | participant | 449˙460.00 |
10 |
ISTITUTO GIANNINA GASLINI
Organization address
address: VIA GEROLAMO GASLINI 5 contact info |
IT (GENOVA) | participant | 438˙014.40 |
11 |
CHARITE - UNIVERSITAETSMEDIZIN BERLIN
Organization address
address: Chariteplatz 1 contact info |
DE (BERLIN) | participant | 370˙372.14 |
12 |
THE LEEDS TEACHING HOSPITALS NATIONAL HEALTH SERVICE TRUST
Organization address
address: ST JAMES'S UNIVERSITY HOSPITAL, BECKETT STREET contact info |
UK (LEEDS) | participant | 344˙450.71 |
13 |
FOUNDATION FOR RESEARCH AND TECHNOLOGY HELLAS
Organization address
address: N PLASTIRA STR 100 contact info |
EL (HERAKLION) | participant | 339˙621.00 |
14 |
UNIVERSITA' DEGLI STUDI DI MILANO-BICOCCA
Organization address
address: PIAZZA DELL'ATENEO NUOVO 1 contact info |
IT (MILANO) | participant | 331˙808.10 |
15 |
THE UNIVERSITY OF BIRMINGHAM
Organization address
address: Edgbaston contact info |
UK (BIRMINGHAM) | participant | 327˙319.60 |
16 |
European CanCer Organisation
Organization address
address: Avenue E. Mounier 83 contact info |
BE (Brussels) | participant | 320˙723.20 |
17 |
Osterreichische Kinder-Krebs-Hilfe verband der Osterreichischen kinder krebs hilfe organisationen
Organization address
address: Borschkegasse 1/7 contact info |
AT (Wien) | participant | 283˙214.99 |
18 |
CONSORZIO INTERUNIVERSITARIO CINECA
Organization address
address: Via Magnanelli 6/3 contact info |
IT (CASALECCHIO DI RENO) | participant | 273˙791.25 |
19 |
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM
Organization address
address: 's Gravendijkwal 230 contact info |
NL (ROTTERDAM) | participant | 266˙994.00 |
20 |
FUNDACION PARA LA INVESTIGACION DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA
Organization address
address: AVENIDA CAMPANAR 21 contact info |
ES (VALENCIA) | participant | 263˙128.00 |
21 |
CENTRE INTERNATIONAL DE RECHERCHE SUR LE CANCER
Organization address
address: Cours Albert-Thomas 150 contact info |
FR (LYON CEDEX 08) | participant | 257˙763.29 |
22 |
UNIVERSITY OF SOUTHAMPTON
Organization address
address: Highfield contact info |
UK (SOUTHAMPTON) | participant | 225˙389.50 |
23 |
LANDESHAUPTSTADT STUTTGART
Organization address
address: SCHMALESTRASSE 9-13 contact info |
DE (Stuttgart) | participant | 210˙981.50 |
24 |
UNIVERSITA DEGLI STUDI DI PADOVA
Organization address
address: VIA 8 FEBBRAIO 2 contact info |
IT (PADOVA) | participant | 193˙311.30 |
25 |
ACADEMISCH ZIEKENHUIS LEIDEN
Organization address
address: Albinusdreef 2 contact info |
NL (LEIDEN) | participant | 154˙383.00 |
26 |
GDANSKI UNIWERSYTET MEDYCZNY
Organization address
address: ULICA M SKLODOWSKIEJ CURIE 3A contact info |
PL (GDANSK) | participant | 148˙915.60 |
27 |
UNIVERSITAETSKLINIKUM ESSEN
Organization address
address: HUFELANDSTRASSE 55 contact info |
DE (ESSEN) | participant | 146˙970.36 |
28 |
CENTRE ANTICANCEREUX LEON BERARD
Organization address
address: RUE LAENNEC 28 contact info |
FR (LYON) | participant | 130˙152.00 |
29 |
ESQH VIENNA OFFICE - EUROPAISCHE GESELLSCHAFT FUR QUALITAT IM GESUNDHEITSWESEN - WIENER BURO VEREIN
Organization address
address: DOMINIKANERBASTEI 10 2 STOCK contact info |
AT (VIENNA) | participant | 111˙960.00 |
30 |
WESTFAELISCHE WILHELMS-UNIVERSITAET MUENSTER
Organization address
address: SCHLOSSPLATZ 2 contact info |
DE (MUENSTER) | participant | 70˙000.00 |
31 |
ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS
Organization address
address: 3 Avenue Victoria contact info |
FR (PARIS) | participant | 69˙304.80 |
32 |
UNIVERSITY OF LEEDS
Organization address
address: WOODHOUSE LANE contact info |
UK (LEEDS) | participant | 66˙656.50 |
33 |
UNIVERSITEIT GENT
Organization address
address: SINT PIETERSNIEUWSTRAAT 25 contact info |
BE (GENT) | participant | 54˙480.40 |
34 |
KAROLINSKA INSTITUTET
Organization address
address: Nobels Vag 5 contact info |
SE (STOCKHOLM) | participant | 27˙860.80 |
Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.
'ENCCA aims to establish a durable, European Virtual Institute clinical and translational research in childhood and adolescent cancers that will define and implement an integrated research strategy and will facilitate the necessary investigator-driven clinical trials to introduce the new generation of biologically targeted drugs into standard of care for children and adolescents with cancer. This will lead to more efficacious and less toxic therapies that will maximise the quality of life of the increasing number of survivors of cancer at a young age in Europe and allow them to assume their proper place in society. This biologically-driven research agenda will improve training of the clinical investigators and translational scientists of the future to spread excellence, increase capacity to participate in research and monitor outcomes across Europe. Patients and their families will be full partners and will be better informed about the need for and processes of clinical research. They will be in a better situation to care from their long term health risks for children. Drug development will be accelerated in partnership with industry through improved access to young patients with cancer, to academic expertise in care, clinical and biological research. All of this will be achieved with respect for the highest ethical and patient safety standards. ENCCA will bring all stakeholders to the table in a timely and efficacious manner. It will address the needs of all the current multinational clinical trial groups for the benefit of children with cancer. It will provide them with common tools and approaches to solve the bottlenecks in testing new therapeutic strategies for those rare diseases in a vulnerable age group and in running a competitive clinical research agenda. Ongoing efforts to coordinate EU and US clinical research will be reinforced. ENCCA will be led by the most active EU institutes in the field (31), recognised as being at the forefront of excellence.'
An EU-funded project is establishing a European Virtual Institute for research in childhood and adolescent cancers. This will facilitate clinical trials for introducing new therapeutic drugs and maximise quality of life for the increasing number of childhood cancer survivors.
"Multimodular biomarker analysis workflow for diagnosis, prognosis and monitoring of drug treatment response in bladder cancer"
Read MoreGaining sage on the Epoetins' saga: assessing long term risks and advancing towards better Epoetin driven treatment modalities
Read More